USA - NASDAQ:ELAB - US73017P2011 - Common Stock
The current stock price of ELAB is 5.43 USD. In the past month the price decreased by -11.15%. In the past year, price decreased by -94.15%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 51.43 | 31.13B | ||
| KVUE | KENVUE INC | 15.88 | 32.61B | ||
| ELF | ELF BEAUTY INC | 22.78 | 3.99B | ||
| BRBR | BELLRING BRANDS INC | 13.35 | 3.65B | ||
| COTY | COTY INC-CL A | 19.55 | 3.25B | ||
| IPAR | INTERPARFUMS INC | 16.77 | 2.82B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 7.25 | 869.27M | ||
| OLPX | OLAPLEX HOLDINGS INC | 18.17 | 727.12M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 6.62 | 451.94M | ||
| USNA | USANA HEALTH SCIENCES INC | 9.86 | 352.98M | ||
| HNST | HONEST CO INC/THE | 50.1 | 278.73M | ||
| NATR | NATURES SUNSHINE PRODS INC | 17.79 | 294.94M |
PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. The company is headquartered in Newport Beach, California and currently employs 2 full-time employees. The company went IPO on 2023-11-21. The Company’s portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.
PMGC HOLDINGS INC
120 Newport Center Drive, Ste 250
Newport Beach CALIFORNIA US
Employees: 3
Phone: 18884454886
PMGC Holdings, Inc. is a physician-dispensed skincare company, which engages in the research and development of skincare formulations. The company is headquartered in Newport Beach, California and currently employs 2 full-time employees. The company went IPO on 2023-11-21. The Company’s portfolio consists of three wholly owned subsidiaries: Northstrive Biosciences Inc., PMGC Research Inc., and PMGC Capital LLC. Northstrive Biosciences Inc. is a biopharmaceutical company focusing on the development and acquisition of cutting-edge aesthetic medicines. Its lead asset, EL-22, is leveraging a first-in-class engineered probiotic approach to address obesity’s pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. PMGC Research Inc. is a research and development subsidiary of the Company, which is focused on advancing the frontiers of scientific discovery. PMGC Capital LLC is a multi-strategy investment vehicle engaging in investing, lending, and seeking diversified investment opportunities across various markets.
The current stock price of ELAB is 5.43 USD. The price increased by 0.18% in the last trading session.
ELAB does not pay a dividend.
ELAB has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
PMGC HOLDINGS INC (ELAB) has a market capitalization of 2.28M USD. This makes ELAB a Nano Cap stock.
The outstanding short interest for PMGC HOLDINGS INC (ELAB) is 137.73% of its float.
ChartMill assigns a fundamental rating of 2 / 10 to ELAB. While ELAB has a great health rating, there are worries on its profitability.
Over the last trailing twelve months ELAB reported a non-GAAP Earnings per Share(EPS) of -320.19. The EPS increased by 7.83% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -69.45% | ||
| ROE | -93.79% | ||
| Debt/Equity | 0 |